-transparent.png){kind=logo}
5-Methoxypsoralen (5-MOP, Bergapten) was evaluated as a potential photosensitizing drug in oral photochemotherapy of psoriasis. Treatment results indicate that (1) 5-MOP is as effective as, and in high doses more effective than, 8-methoxypsoralen in clearing psoriatic lesions; (2) therapeutic doses of 5-MOP do not lead to erythema; the acute side-effects of 8-MOP PUVA therapy--erythema, blistering, pruritus--are thus avoided; (3) even high doses of 5-MOP are not followed by nausea. 5-MOP PUVA therapy thus represents a real alternative to 8-MOP PUVA, its advantages over 8-MOP PUVA being greater safety and patient acceptance.
Related Publications
H Hönigsmann, and
E Jaschke, and
F Gschnait, and
W Brenner, and
P Fritsch, and
K Wolff
February 1988,
Journal of the American Academy of Dermatology,
H Hönigsmann, and
E Jaschke, and
F Gschnait, and
W Brenner, and
P Fritsch, and
K Wolff
January 1983,
Sbornik vedeckych praci Lekarske fakulty Karlovy university v Hradci Kralove,
H Hönigsmann, and
E Jaschke, and
F Gschnait, and
W Brenner, and
P Fritsch, and
K Wolff
January 1982,
Archives of dermatological research,
H Hönigsmann, and
E Jaschke, and
F Gschnait, and
W Brenner, and
P Fritsch, and
K Wolff
January 1981,
The British journal of dermatology,
H Hönigsmann, and
E Jaschke, and
F Gschnait, and
W Brenner, and
P Fritsch, and
K Wolff
November 2001,
The British journal of dermatology,
H Hönigsmann, and
E Jaschke, and
F Gschnait, and
W Brenner, and
P Fritsch, and
K Wolff
June 1976,
Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete,
H Hönigsmann, and
E Jaschke, and
F Gschnait, and
W Brenner, and
P Fritsch, and
K Wolff
May 1978,
Nihon Hifuka Gakkai zasshi. The Japanese journal of dermatology,
H Hönigsmann, and
E Jaschke, and
F Gschnait, and
W Brenner, and
P Fritsch, and
K Wolff
May 1983,
The British journal of dermatology,
H Hönigsmann, and
E Jaschke, and
F Gschnait, and
W Brenner, and
P Fritsch, and
K Wolff
January 1981,
Archives of dermatological research,
H Hönigsmann, and
E Jaschke, and
F Gschnait, and
W Brenner, and
P Fritsch, and
K Wolff
November 1980,
Lancet (London, England),
